Erythropoietin biosimilar (Incepta Pharmaceuticals)
促红细胞生成素生物类似药 (Incepta Pharmaceuticals)
Report date: 2025/07/14 16:28:48
Base Information
Drug NameErythropoietin biosimilar (Incepta Pharmaceuticals)
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2012/08/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesIncepta Pharmaceuticals Ltd
China Registration ClassN/A
Develop Information
Active CompaniesIncepta Pharmaceuticals Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A